The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Preoperative imaging alone has not been shown to make sentinel lymph node biopsy (SLNB) omission safe for every patient with T1 invasive lobular carcinoma (ILC). Recent retrospective evidence found occult nodal metastases in about one in five clinically node-negative ILC patients, but the reported groups were not limited to T1 tumors. MRI had a high negative predictive value in one mixed-histology cohort, yet the omission trials informing current guidance did not routinely use breast MRI. The evidence therefore supports individualized risk assessment, not a blanket imaging-based rule.
The supplied title resembles a specific retrospective study, but no paper with that exact title was identified. The findings below summarize the closest reported evidence; they should not be mistaken for results from a study bearing that title.
As an Amazon Associate I earn from qualifying purchases.
What the evidence says about T1 ILC
The central limitation is that the available nodal-positivity figures are not T1-specific. A 2026 Annals of Surgical Oncology series included 491 clinically node-negative patients with early-stage ILC: 392 (79.8%) had no nodal metastases and 99 (20.2%) had metastases, ranging from pN1mi to pN3. A separate single-institution analysis reported nodal positivity in 19.8% of 189 patients meeting INSEMA eligibility criteria and 18.4% of 99 meeting SOUND eligibility criteria. Those eligibility-based groups also cannot be treated as T1-only estimates.
Recommended Free Tools
These results indicate that a clinically negative axilla does not exclude pathological nodal disease in ILC. They do not establish the probability for an individual with a particular T1 tumor, nor do they show that all detected disease would alter treatment or outcomes. The reported positive category includes micrometastases (pN1mi) as well as larger-volume disease.
#1 Best Overall
Why omission-trial criteria do not settle the question for ILC
ASCO recommendations support omitting SLNB for carefully selected patients with early-stage invasive ductal carcinoma (IDC) and negative axillary imaging. A 2026 Annals of Surgical Oncology analysis focused on ILC cautions that those criteria cannot simply be transferred to lobular cancer. ILC was underrepresented in the evidence underpinning de-escalation, and the retrospective ILC series found substantial occult nodal positivity.
INSEMA and SOUND provide important context for axillary de-escalation, but ASCO’s guideline update notes that breast MRI was not routinely used in either trial. Their omission results therefore do not establish what MRI adds to selection for SLNB omission. Nor does the existence of a trial protocol titled “No Axillary Surgery in Early Breast Cancer (OXIGENATE)” (NCT07370571) establish its design, eligibility, status, or findings.
Rank #2
- The 2024 DOT Medical Examination Guide Book provides a detailed guide to the physical standards to be qualified to drive a CMV. Medical exam handbook helps you understand medical qualification and the examination process.
- Regulation Alert. The FMCSA update to its Medical Advisory Criteria (Appendix A to Part 391) and accompanying medical guidance 1/24/24. All prior versions of medical guidance have been superseded. Certified Medical Examiners use the medical guidance but are not obligated by law to follow the guidance. No physical qualification regulatory standards in 391.41(b) have changed.
- Includes. Tabbed pages for quick and easy referencing, 100+ illustrations, handouts, and addresses the regulatory side of driver wellness. Alternative vision standard 391.44 and the Insulin-treated diabetes mellitus (ITDM) rule in 391.46.
- Variety of Topics. Purpose of exam, explanation, requirements, and guidelines for exam, Medical Registry, regulations, wellness and demands placed on commercial motor drivers, forms and recordkeeping, ADA and HIPAA info, and FAQs.
- Specifications: 5” x 7" Medical Exams Handbook, English, Spiralbound. Copyright 2024.
What ultrasound and MRI can—and cannot—tell you
A 2026 Clinical Breast Cancer cohort included 661 clinically node-negative patients with tumors no larger than 50 mm. Its imaging figures describe that cohort, not a T1 ILC subgroup:
Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstall| Test | Specificity | Negative predictive value | How to interpret the result |
|---|---|---|---|
| Axillary ultrasound | 95% | 80% | A negative result was less reassuring for excluding node-negative status than the MRI result in this cohort; ultrasound specificity was higher. |
| MRI | 79% | 98% | A negative result had a high negative predictive value in this cohort, but that figure is not established specifically for T1 ILC or as proof that surgery can be safely omitted. |
These measures answer different questions. Specificity concerns correctly identifying patients without the target finding among those who do not have it; negative predictive value concerns the proportion of negative results that are truly negative in the population tested. Predictive value depends on the population and prevalence, so these numbers should not be treated as universal test properties or as interchangeable measures of safety.
Rank #3
- Keep Track of Your Health and Medical records — My Health Journal is a great way to use it as an agenda during doctor visits and manage your medical information and keep everything in one convenient place. You can take control of your health, prepare for emergencies or natural disasters, and have quick and easy access to your medical history with this comprehensive health records book.
- Helps you Manage and Organize Your Medical Information — All your medical records in one place; your health history at your fingertips with space for your medical reports. This organizer is the best way to keep doctors' visits, therapy sessions, and other medical appointments organized. It helps to prevent medical errors and enable you to use appointment time more effectively.
- Saves Your Medical History — My Health Journal is great for keeping your medical history. It includes a personal information section with emergency contact notifications, doctor contact list, insurance information, prescribed medications, Immunization records, surgical history, dental and eye exam records, etc. It also helps you arrange and log all appointments and expenses.
- Comprehensive and Easy to Use — Comprehensive yet easy to fill out and clear to read. My Health Journal Medical Records Organizer enables individuals and family caregivers to have their important medical records and documents at their fingertips.
- Compact Size Allows for Convenient Travel — Easy to take directly to the doctor's office to ensure all important information is stored in one place.
In the same cohort, lobular histology was not an independent predictor of SLNB positivity or nodal upstaging, and there were no axillary recurrences at a median follow-up of 49.3 months. This is evidence that can support discussion of de-escalation, but it does not cancel the ILC-specific series’ occult-node findings: the studies differ in cohort and design, and the recurrence observation is limited to the reported follow-up.
Why MRI interpretation matters in lobular cancer
ILC may present subtle axillary abnormalities. An MRI study available as PMC10075493 emphasizes attention to lymph-node cortical contour and thickness. It recommends targeted second-look ultrasound and biopsy when MRI shows focal cortical thickening, to reduce the chance of underestimating nodal burden. MRI’s high negative predictive value in a separate cohort should not be read as meaning every suspicious node can be ignored or that image interpretation is independent of technique and reader judgment.
Rank #4
- YOUR GO-TO MEDICAL JOURNAL - The Portage personal medical notebook has everything you need to track your daily drug intake, blood sugar levels, blood pressure, and more. Plus, each page contains spaces for the day, date, time, and extra notes
- DESIGNED FOR USE ON THE GO - A spiral design on our medical records journal allows the notebook to lay flat on a desk or table, while the sturdy cover makes it easy to take notes while standing or on the go
- THE IDEAL SIZE - This professional reporter’s notebook measures 4” x 8”, meaning it doesn’t take up too much room in your bag, desk, or table and is able to fit in a pant pocket or coat pocket if you are on the move
- LARGE FORMAT - Extra-large printing with extra wide tabs and form fields make it easy to view your health and vital statistics at a glance. The simple structure of the daily medical planner and log allows you to track what is important in an organized format
- A GREAT VALUE - Sold in a pack of 12 each health journal contains 70 pages, providing you with a full year of medication tracking, blood pressure readings and blood sugar level reports
Factors that may change the balance
The 2026 ILC series identified tumor size as the main determinant of nodal involvement. Pleomorphic variants tended to carry a higher nodal burden. In the single-institution analysis using INSEMA and SOUND criteria, younger age was associated with nodal positivity. These are risk modifiers from retrospective analyses, not a validated calculator or stand-alone thresholds for deciding whether to omit SLNB.
- Tumor size: the reported main determinant of nodal involvement; the available figures do not provide a T1-specific risk estimate.
- Histologic variant: pleomorphic ILC tended toward greater nodal burden, though the evidence presented does not define a treatment cutoff.
- Age: younger age was associated with positivity in one eligibility-based analysis, not established here as a universal rule.
- Imaging findings: a negative study is informative but does not by itself resolve the ILC-specific uncertainty around occult disease.
How to frame the surgical decision
SLNB remains the standard axillary staging procedure in the background evidence summarized here. The practical question is whether a particular patient meets the criteria and circumstances for omission, and whether knowing nodal status would change subsequent management. Because the reported ILC positivity rates are not T1-specific and the omission-trial evidence does not test MRI-guided selection directly, a decision should not be based on a negative image alone.
Best Value
- CREATED BY PROFESSIONALS: Our proRound Medical Rounds Notebook was thoughtfully designed by top medical professionals to make your shift easier and more organized. The proRound notebook is perfect for medical students, physicians assistants, and nurse practitioners training for hospital care.
- POCKET SIZED: The proRound spiral medical rounding notebook measures 4.5” x 7” to perfectly fit a standard white coat pocket.
- PRE-FILLED TEMPLATE: Each page is designed with a standard template with room for specific patient information, including current medications, labs, and overall assessment. With the template, you’ll never miss pertinent information.
- PLENTY OF ROOM: The proRound journal contains 75 pages, with enough space for 35 patient encounters per notebook. ProRound has a thick cover and a sturdy back so you can write on the go.
- COMMON ABBREVIATIONS: Quick-Notes section that allows you to interpret and utilize common abbreviations, shorthand lab trees, and calculations.
For a clinical discussion, the relevant points are whether the tumor is truly within the intended T1 category, whether axillary imaging was performed and interpreted with attention to ILC’s subtle nodal features, what a positive sentinel node would change in the treatment plan, and how the individual fits the evidence behind omission criteria. The studies summarized here do not provide a universal threshold at which imaging makes SLNB unnecessary.
Quick Recap
What remains uncertain
- The T1-specific rate of nodal positivity in ILC patients with negative preoperative imaging is not established by the reported sample sizes.
- The incremental benefit of MRI for selecting ILC patients to omit SLNB is not established by INSEMA or SOUND, which did not routinely use breast MRI.
- The retrospective cohorts may differ in selection, imaging protocols, and follow-up, limiting direct comparison.
- The clinical significance of nodal micrometastases is not resolved by simply counting them as node-positive.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
